Skip to main content
. 2020 May 24;8(5):132. doi: 10.3390/biomedicines8050132

Table 2.

Antituberculosis activity (MIC, µM) of test compounds.

Mycobacterial Strains MIC (µM)
Brassicasterol Rifampicin
Mtb a 1.9 ± 0.12 0.1 ± 0.01
Mtb-CI1 b 2.0 ± 0.13 0.2 ± 0.02
Mtb-CI2 b 2.4 ± 0.15 0.2 ± 0.03
Mtb-CI3 b 2.2 ± 0.14 0.3 ± 0.02
Mtb-CI4 b 2.1 ± 0.14 0.3 ± 0.02
Mtb-CI5 b 1.9 ± 0.13 0.1 ± 0.02
Mtb-CI6 b 1.9 ± 0.13 0.3 ± 0.01
Mtb-CI7 b 2.1 ± 0.14 0.2 ± 0.01
Mtb-CI8 b 1.9 ± 0.11 0.4 ± 0.03
Mtb-CI9 b 2.1 ± 0.13 0.3 ± 0.02
Mtb-CI10 b 2.0 ± 0.15 0.1 ± 0.01

All recorded values are means ± standard deviation (SD) of three independent experiments assayed in triplicate. a Mtb: Mycobacterium tuberculosis (reference strain; H37Rv CNCTC My 331-88/ATCC 27294); b Mtb: Mycobacterium tuberculosis clinical strains; MIC: minimum inhibitory concentration. All presented data were processed by PRISM software (GraphPad Software, Inc., La Jolla, CA, USA; version 8.0).